FindTrial
Sign In

This is a real world observational study to evaluate the role of Enoxaparin in Anti-Thyroid antibodies positive IVF pregnancies on maternal and fetal outcomes

Real world observational study to evaluate the role of Enoxaparin in Anti Thyroid antibodies positive In-vitro Fertilization (IVF) pregnancies on maternal and fetal outcomes - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/087816
Enrollment
80
Registered
2025-05-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Enoxaparin injection: Enoxaparin is low molecular weight heparin that is used in gynaecology for the following approved indications in India Intervention2: NA: NA Control Intervention1:

Sponsors

Dr G A Rama Raju
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Infertile female patients 2) Age 20 to 40 years 3) Positive for Antithyroid antibodies -Anti TPO antibodies and Anti-thyroglobulin antibodies 4) BMI 18 to 40 Kg per m2

Exclusion criteria

Exclusion criteria: 1) Patients with known history of drug allergy 2) Patients suffering from HIV, Hepatitis B, Hepatitis C 3) Patients suffering from any malignancy 4) Patient with active major bleeding, thrombocytopenia

Design outcomes

Primary

MeasureTime frame
Proportion of pregnancies that resulted in Live birthTimepoint: Proportion of pregnancies that resulted in Live birth—

Secondary

MeasureTime frame
1) Obstetric complications a) Proportion of patients having Pregnancy Induced Hypertension b) Proportion of patients having Oligohydraminos c) Proportion of patients having Intra Uterine Growth Restriction d) Proportion of patients having Gestational Diabetes Mellitus e) Proportion of patients having Bleeding in First trimester f) Proportion of patients having Abruptio Placenta 2) Fetal complications a) Proportion of Full term birth b) Proportion of Low Birth weight babiesTimepoint: 1) Obstetric complications a) Proportion of patients having Pregnancy Induced Hypertension b) Proportion of patients having Oligohydraminos c) Proportion of patients having Intra Uterine Growth Restriction d) Proportion of patients having Gestational Diabetes Mellitus e) Proportion of patients having Bleeding in First trimester f) Proportion of patients having Abruptio Placenta 2) Fetal complications a) Proportion of Full term birth b) Proportion of Low Birth weight babies—

Countries

India

Contacts

Public ContactDr G A Rama Raju

Krishna IVF Clinic

krishnaivf@gmail.com9849110004

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026